Nitric oxide mediates glial-induced neurodegeneration in Alexander disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26608817.
- Also identified by DOI 10.1038/ncomms9966 and PMC identifier 4674772.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Glia play critical roles in maintaining the structure and function of the nervous system; however, the specific contribution that astroglia make to neurodegeneration in human disease states remains largely undefined. Here we use Alexander disease, a serious degenerative neurological disorder caused by astrocyte dysfunction, to identify glial-derived NO as a signalling molecule triggering astrocyte-mediated neuronal degeneration. We further find that NO acts through cGMP signalling in neurons to promote cell death. Glial cells themselves also degenerate, via the DNA damage response and p53. Our findings thus define a specific mechanism for glial-induced non-cell autonomous neuronal cell death, and identify a potential therapeutic target for reducing cellular toxicity in Alexander disease, and possibly other neurodegenerative disorders with glial dysfunction.
Medical subject headings
- Alexander Disease
- Astrocytes
- Glial Fibrillary Acidic Protein
- Neurons
- Nitric Oxide